Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Prepaid Assets (2020 - 2025)

Oncology Institute's Prepaid Assets history spans 6 years, with the latest figure at $3.0 million for Q4 2025.

  • For Q4 2025, Prepaid Assets fell 25.86% year-over-year to $3.0 million; the TTM value through Dec 2025 reached $3.0 million, down 25.86%, while the annual FY2025 figure was $3.0 million, 25.86% down from the prior year.
  • Prepaid Assets reached $3.0 million in Q4 2025 per TOI's latest filing, down from $3.6 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $11.2 million in Q4 2021 to a low of $82245.0 in Q3 2021.
  • Average Prepaid Assets over 5 years is $5.0 million, with a median of $4.2 million recorded in 2023.
  • Peak YoY movement for Prepaid Assets: crashed 59.32% in 2021, then surged 9207.56% in 2022.
  • A 5-year view of Prepaid Assets shows it stood at $11.2 million in 2021, then crashed by 38.23% to $6.9 million in 2022, then crashed by 41.47% to $4.0 million in 2023, then decreased by 0.49% to $4.0 million in 2024, then decreased by 25.86% to $3.0 million in 2025.
  • Per Business Quant, the three most recent readings for TOI's Prepaid Assets are $3.0 million (Q4 2025), $3.6 million (Q3 2025), and $2.8 million (Q2 2025).